AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2010
Feb 17, 2010
30016_dirs_2010-02-17_49075c4a-71f7-4b4e-8357-36f9145203d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2010-02-14
Reporting Person: MURRAY ROBERT J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-02-14 | Common Stock | M | 1309 | — | Acquired | 35398 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-14 | Non-Qualified Stock Option (right to buy) | $53.3100 | A | 5962 | Acquired | 2017-02-13 | Common Stock (4962) | Direct |
| 2010-02-14 | Restricted Stock Unit | $ | A | 516 | Acquired | Common Stock (516) | Direct | |
| 2010-02-14 | Restricted Stock Unit | $ | M | 1309 | Disposed | Common Stock (1309) | Direct |
Footnotes
F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock becomes exercisable on 2/14/2011.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest 100% one year from the date of grant.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 26